Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
admission, AllocetraTM, Allocetra™for, Allocetra™to, Allocetra™would, anti, APACHEII, BGU, CEO, contractor, coping, COSO, coupled, depict, deviate, died, embedded, exceeded, finder, foremost, gender, goal, Haddasah, hard, Hershkovitz, ICU, IIb, Italy, Jumpstart, legacy, mandatorily, markedly, meant, multiplied, Negev, noncontrolling, nonpublic, obesity, omitted, OTS, proportionate, purposefully, QP, rescheduled, residual, room, ROU, Sep, Sequential, simply, slowest, SOFA, Spain, spouse, surfaced, swift, Thirty, tort, uncertificated, unpermitted, USD, Wuhan
Removed:
abovementioned, allocation, attractive, bona, cGLP, commenced, Dalia, deed, defect, defector, deposit, deter, disqualification, disqualified, execution, fide, filer, fit, forward, fulfill, hereinafter, inventor, leasehold, motor, peer, postpone, prepaid, reflecting, remeasured, rendering, retrospectively, revised, rotation, seniority, thousand, undermine, waiving
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Ordinary Shares
- 4.3 Enlivex Therapeutics LTD. 2019 Global Share Incentive Plan
- 4.8 Employment Agreement Between the Company and Oren Hershkovitz, Dated As of November 16, 2019
- 4.15 Research Agreement, Between the Company and Cell Generation (C-G) LTD., Dated May 12, 2019
- 8.1 List of Subsidiaries of Enlivex Therapeutics LTD
- 12.1 Certification
- 12.1 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Consent of Yarel + Partners
- Download Excel data file
- View Excel data file
ENLV similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form F-3 (Registration No . 333-232009 and 333-232413) and the Registration Statements on Form S-8 (Registration No. 333-203114 and 333-210459) of Enlivex Therapeutics Ltd. of our report dated April 2, 2020 with respect to the consolidated financial statements of Enlivex Therapeutics Ltd. included in this Annual Report on Form 20-F of Enlivex Therapeutics Ltd. for the year ended December 31, 2019 filed with the Securities and Exchange Commission.
Yarel + Partners
/s/ Yarel + Partners
Tel- Aviv, Israel
April 30, 2020